IR
63
3
SRE
63
-3
L
62
2
SYK
64
-4
MUR
43
3
NWL
44
-4
LB
34
8
C
58
-2
DVN
16
3
SIG
43
3
DG
2
-6
HAS
30
2
IPG
49
10
LUV
39
-5
BIIB
26
2
HUM
48
6
JNJ
41
2
AES
39
-4
CAH
47
3
CL
56
5
IR
63
3
SRE
63
-3
L
62
2
SYK
64
-4
MUR
43
3
NWL
44
-4
LB
34
8
C
58
-2
DVN
16
3
SIG
43
3
DG
2
-6
HAS
30
2
IPG
49
10
LUV
39
-5
BIIB
26
2
HUM
48
6
JNJ
41
2
AES
39
-4
CAH
47
3
CL
56
5
Financhill
Back

Stoke Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20

STOK
Stoke Therapeutics

Last Price:
11.61
Seasonality Move:
-1.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Stoke Therapeutics Price Quote

$11.61
+0.30 (+2.65%)
(Updated: November 21, 2024 at 1:35 PM ET)

Stoke Therapeutics Key Stats

Sell
20
Stoke Therapeutics (STOK) is a Sell
Day range:
$11.08 - $11.64
52-week range:
$3.77 - $17.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
36.07
P/B ratio:
2.71%
Volume:
265.1K
Avg. volume:
468.8K
1-year change:
171.22%
Market cap:
$629.2M
Revenue:
$8.8M
EPS:
$-2.1

How Much Does Stoke Therapeutics Make?

Is Stoke Therapeutics Growing As A Company?

  • What Is Stoke Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.48%
  • What Is Stoke Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Stoke Therapeutics Stock Price Performance

What Is Stoke Therapeutics 52-Week High & Low?

Stoke Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Stoke Therapeutics?

Is Stoke Therapeutics Cash Flow Positive?

  • What Is STOK Cash Flow From Operations?
    Cash flow from operations (TTM) is -$84.3M
  • What Is Stoke Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $137.9M
  • What Is Stoke Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$93.5M

Stoke Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    STOK return on invested capital is -55.64%
  • What Is Stoke Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -41.37%
  • What Is STOK Return On Equity?
    ROE is a measure of profitability and is -55.64%

Stoke Therapeutics Earnings Date & Stock Price

Stoke Therapeutics Competitors

Stoke Therapeutics Dividend Yield

Stoke Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 13.23%
Revenue: 47.94% 35.94%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 22.29
Upside from Last Price: 97.04%

Major Shareholders

  • How many STOK shares are owned by institutional investors?
    85.6M STOK shares are owned by institutional investors
  • How many STOK shares are owned by insiders?
    510.6K STOK shares are owned by insiders